Home › NDC Lookup › RxCUI directory › RxCUI 2003755

1.14 ML sarilumab 132 MG/ML Auto-Injector — RxCUI 2003755

Name: 1.14 ML sarilumab 132 MG/ML Auto-Injector (RxCUI 2003755)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2003755 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2003755

Official name1.14 ML sarilumab 132 MG/ML Auto-Injector

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known assarilumab 150 MG per 1.14 ML Auto-Injector; sarilumab 150 MG in 1.14 ML Auto-Injector

FDA products mapped4

Package NDCs mapped8

Reported Medicaid activity (SDUD)5,765 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sarilumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Kevzara targets a specific protein called IL-6 that drives inflammation in your joints and body. Unlike traditional DMARDs (like methotrexate), which work more broadly, Kevzara zer...
What exactly is Kevzara treating — and how is it different from other arthritis medicines?
You'll use a pre-filled syringe or pre-filled pen, injecting it under the skin — usually in the belly, thigh, or upper arm. Before injecting, let the pre-filled syringe sit at room...
How do I give myself this injection at home?

📖 Read our full Sarilumab Injection guide →

🕸️ Concept Web — How 1.14 ML sarilumab 132 MG/ML Auto-Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1.14 ML sarilumab 132 MG/ML Auto-Injector RxCUI 2003755 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Sarilumab 1923319 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kevzara 1923334 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Sarilumab Auto-Injector 2003754 SCDF
- Sarilumab Injectable Product 1923331 SCDG
- Sarilumab Auto-Injector [Kevzara] 2003756 SBDF
- Kevzara Injectable Product 1923337 SBDG
- Auto-Injector 1649570 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Sarilumab 132 MG/ML 1923330 SCDC
- 1.14 ML sarilumab 132 MG/ML Auto-Injector [Kevzara] 2003757 SBD
- Sarilumab 132 MG/ML [Kevzara] 1923335 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Sarilumab 132 MG/ML SCDC · 1923330
Sarilumab Auto-Injector SCDF · 2003754
Sarilumab Injectable Product SCDG · 1923331

Brand-Name Concepts

1.14 ML sarilumab 132 MG/ML Auto-Injector [Kevzara] SBD · 2003757
Sarilumab 132 MG/ML [Kevzara] SBDC · 1923335
Sarilumab Auto-Injector [Kevzara] SBDF · 2003756
Kevzara Injectable Product SBDG · 1923337
Kevzara BN · 1923334

📦 FDA Products & Package NDCs

4 products · 8 package NDCs

8 package NDCs map to RxCUI 2003755 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00024-5908-01	2 SYRINGE in 1 PACKAGE (0024-5908-01) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2017-05-22
00024-5908-02	2 SYRINGE in 1 PACKAGE (0024-5908-02) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2017-05-22
00024-5910-01	2 SYRINGE in 1 PACKAGE (0024-5910-01) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2017-05-22
00024-5910-02	2 SYRINGE in 1 PACKAGE (0024-5910-02) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2017-05-22
00024-5920-01	2 SYRINGE in 1 PACKAGE (0024-5920-01) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2018-04-13
00024-5920-02	2 SYRINGE in 1 PACKAGE (0024-5920-02) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2018-04-13
00024-5922-01	2 SYRINGE in 1 PACKAGE (0024-5922-01) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2018-04-13
00024-5922-02	2 SYRINGE in 1 PACKAGE (0024-5922-02) / 1.14 mL in 1 SYRING...	KEVZARA	Sanofi-Aventis U.S. LLC	2018-04-13

Observed labelers: Sanofi-Aventis U.S. LLC (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.